214 related articles for article (PubMed ID: 23372684)
1. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
6. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
8. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
9. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
Commun Biol; 2019; 2():162. PubMed ID: 31069271
[TBL] [Abstract][Full Text] [Related]
10. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile of fibrovascular membranes from patients with proliferative diabetic retinopathy.
Yoshida S; Ogura A; Ishikawa K; Yoshida A; Kohno R; Yamaji Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
Br J Ophthalmol; 2010 Jun; 94(6):795-801. PubMed ID: 19919945
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin-1 expression in proliferative vitreoretinopathy and in epiretinal membranes.
Motulsky E; Salik D; Janssens X; Pion B; Dufrane R; Chaput F; Bolaky N; Gregoire F; Caspers L; Perret J; Willermain F; Delporte C
ScientificWorldJournal; 2014; 2014():876208. PubMed ID: 24688444
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.
Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C
Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905
[TBL] [Abstract][Full Text] [Related]
15. Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes.
Bonente D; Bianchi L; De Salvo R; Nicoletti C; De Benedetto E; Bacci T; Bini L; Inzalaco G; Franci L; Chiariello M; Tosi GM; Bertelli E; Barone V
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298679
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
[TBL] [Abstract][Full Text] [Related]
17. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
Liang Y; Li X; Fan J; Zhao M; Jiang Y
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
19. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
20. Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy.
Crispin M; Gerhart J; Heffer A; Martin M; Abdalla F; Bravo-Nuevo A; Philp NJ; Kuriyan AE; George-Weinstein M
Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):1. PubMed ID: 36723927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
